List of Tables
Table 1. Global Neurotrophins Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Neurotrophins Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Neurotrophins Market Competitive Situation by Manufacturers in 2024
Table 4. Global Neurotrophins Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Neurotrophins Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Neurotrophins Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Neurotrophins Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Neurotrophins Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Neurotrophins, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neurotrophins, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurotrophins, Product Type & Application
Table 12. Global Key Manufacturers of Neurotrophins, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurotrophins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurotrophins as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurotrophins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Neurotrophins Sales by Region (2020-2025) & (K Units)
Table 18. Global Neurotrophins Sales Market Share by Region (2020-2025)
Table 19. Global Neurotrophins Sales by Region (2026-2031) & (K Units)
Table 20. Global Neurotrophins Sales Market Share by Region (2026-2031)
Table 21. Global Neurotrophins Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Neurotrophins Revenue Market Share by Region (2020-2025)
Table 23. Global Neurotrophins Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Neurotrophins Revenue Market Share by Region (2026-2031)
Table 25. North America Neurotrophins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Neurotrophins Sales by Country (2020-2025) & (K Units)
Table 27. North America Neurotrophins Sales by Country (2026-2031) & (K Units)
Table 28. North America Neurotrophins Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Neurotrophins Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Neurotrophins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Neurotrophins Sales by Country (2020-2025) & (K Units)
Table 32. Europe Neurotrophins Sales by Country (2026-2031) & (K Units)
Table 33. Europe Neurotrophins Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Neurotrophins Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Neurotrophins Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Neurotrophins Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Neurotrophins Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Neurotrophins Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Neurotrophins Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neurotrophins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Neurotrophins Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Neurotrophins Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Neurotrophins Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neurotrophins Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Neurotrophins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Neurotrophins Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Neurotrophins Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Neurotrophins Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Neurotrophins Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Neurotrophins Sales (K Units) by Type (2020-2025)
Table 51. Global Neurotrophins Sales (K Units) by Type (2026-2031)
Table 52. Global Neurotrophins Sales Market Share by Type (2020-2025)
Table 53. Global Neurotrophins Sales Market Share by Type (2026-2031)
Table 54. Global Neurotrophins Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Neurotrophins Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Neurotrophins Revenue Market Share by Type (2020-2025)
Table 57. Global Neurotrophins Revenue Market Share by Type (2026-2031)
Table 58. Global Neurotrophins Price (US$/Unit) by Type (2020-2025)
Table 59. Global Neurotrophins Price (US$/Unit) by Type (2026-2031)
Table 60. Global Neurotrophins Sales (K Units) by Application (2020-2025)
Table 61. Global Neurotrophins Sales (K Units) by Application (2026-2031)
Table 62. Global Neurotrophins Sales Market Share by Application (2020-2025)
Table 63. Global Neurotrophins Sales Market Share by Application (2026-2031)
Table 64. Global Neurotrophins Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Neurotrophins Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Neurotrophins Revenue Market Share by Application (2020-2025)
Table 67. Global Neurotrophins Revenue Market Share by Application (2026-2031)
Table 68. Global Neurotrophins Price (US$/Unit) by Application (2020-2025)
Table 69. Global Neurotrophins Price (US$/Unit) by Application (2026-2031)
Table 70. Johnson＆Johnson Company Information
Table 71. Johnson＆Johnson Description and Business Overview
Table 72. Johnson＆Johnson Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Johnson＆Johnson Neurotrophins Product
Table 74. Johnson＆Johnson Recent Developments/Updates
Table 75. Lonza Groups Company Information
Table 76. Lonza Groups Description and Business Overview
Table 77. Lonza Groups Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Lonza Groups Neurotrophins Product
Table 79. Lonza Groups Recent Developments/Updates
Table 80. FibroGen Company Information
Table 81. FibroGen Description and Business Overview
Table 82. FibroGen Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. FibroGen Neurotrophins Product
Table 84. FibroGen Recent Developments/Updates
Table 85. Scil Proteins GmbH Company Information
Table 86. Scil Proteins GmbH Description and Business Overview
Table 87. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Scil Proteins GmbH Neurotrophins Product
Table 89. Scil Proteins GmbH Recent Developments/Updates
Table 90. Merck Serono Company Information
Table 91. Merck Serono Description and Business Overview
Table 92. Merck Serono Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Merck Serono Neurotrophins Product
Table 94. Merck Serono Recent Developments/Updates
Table 95. Scil Proteins GmbH Company Information
Table 96. Scil Proteins GmbH Description and Business Overview
Table 97. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Scil Proteins GmbH Neurotrophins Product
Table 99. Scil Proteins GmbH Recent Developments/Updates
Table 100. PeproTech Company Information
Table 101. PeproTech Description and Business Overview
Table 102. PeproTech Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. PeproTech Neurotrophins Product
Table 104. PeproTech Recent Developments/Updates
Table 105. GE Healthcare Company Information
Table 106. GE Healthcare Description and Business Overview
Table 107. GE Healthcare Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. GE Healthcare Neurotrophins Product
Table 109. GE Healthcare Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Neurotrophins Distributors List
Table 113. Neurotrophins Customers List
Table 114. Neurotrophins Market Trends
Table 115. Neurotrophins Market Drivers
Table 116. Neurotrophins Market Challenges
Table 117. Neurotrophins Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neurotrophins
Figure 2. Global Neurotrophins Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neurotrophins Market Share by Type: 2024 & 2031
Figure 4. Nerve Growth Factor Product Picture
Figure 5. Brain-Derived Neurotrophic Factor Product Picture
Figure 6. Dehydroepiandrosterone Sulfate Product Picture
Figure 7. Other Product Picture
Figure 8. Global Neurotrophins Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Neurotrophins Market Share by Application: 2024 & 2031
Figure 10. Alzheimer'S Disease
Figure 11. Amyotrophic Lateral Sclerosis
Figure 12. Parkinson'S Disease
Figure 13. Other
Figure 14. Global Neurotrophins Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Neurotrophins Market Size (2020-2031) & (US$ Million)
Figure 16. Global Neurotrophins Sales (2020-2031) & (K Units)
Figure 17. Global Neurotrophins Average Price (US$/Unit) & (2020-2031)
Figure 18. Neurotrophins Report Years Considered
Figure 19. Neurotrophins Sales Share by Manufacturers in 2024
Figure 20. Global Neurotrophins Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Neurotrophins Players: Market Share by Revenue in Neurotrophins in 2024
Figure 22. Neurotrophins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Neurotrophins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Neurotrophins Sales Market Share by Country (2020-2031)
Figure 25. North America Neurotrophins Revenue Market Share by Country (2020-2031)
Figure 26. United States Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Neurotrophins Sales Market Share by Country (2020-2031)
Figure 29. Europe Neurotrophins Revenue Market Share by Country (2020-2031)
Figure 30. Germany Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Neurotrophins Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Neurotrophins Revenue Market Share by Region (2020-2031)
Figure 37. China Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Neurotrophins Sales Market Share by Country (2020-2031)
Figure 47. Latin America Neurotrophins Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Neurotrophins Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Neurotrophins Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Neurotrophins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Neurotrophins by Type (2020-2031)
Figure 57. Global Revenue Market Share of Neurotrophins by Type (2020-2031)
Figure 58. Global Neurotrophins Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Neurotrophins by Application (2020-2031)
Figure 60. Global Revenue Market Share of Neurotrophins by Application (2020-2031)
Figure 61. Global Neurotrophins Price (US$/Unit) by Application (2020-2031)
Figure 62. Neurotrophins Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
